Strong Tower Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-44,420	Closed	-$3.07M	–	103
2025 Q2	$3.07M	Buy	44,420 +1,866	+4%	+$127K	0.6%	45
2025 Q1	$2.71M	Buy	42,554 +17,563	+70%	+$1.45M	0.67%	38
2024 Q4	$2.15M	Buy	24,991 +1,467	+6%	+$159K	0.56%	46
2024 Q3	$2.8M	Sell	23,524 -1,636	-7%	-$218K	0.78%	28
2024 Q2	$3.59M	Buy	25,160 +2,395	+11%	+$317K	1.18%	25
2024 Q1	$2.9M	Buy	22,765 +657	+3%	+$78.2K	1.17%	24
2023 Q4	$2.29M	Buy	22,108 +267	+1%	+$26.4K	1.01%	25
2023 Q3	$1.99M	Buy	21,841 +135	+0.6%	+$11.9K	0.99%	25
2023 Q2	$1.76M	Sell	21,706 -912	-4%	-$74.5K	0.83%	26
2023 Q1	$1.8M	Sell	22,618 -634	-3%	-$45K	0.95%	25
2022 Q4	$1.57M	Buy	23,252 +110	+0.5%	+$6.45K	0.94%	24
2022 Q3	$1.15M	Buy	23,142 +328	+1%	+$17.6K	0.69%	36
2022 Q2	$1.27M	Sell	22,814 -608	-3%	-$33.7K	0.69%	31
2022 Q1	$1.3M	Buy	23,422 +1,428	+6%	+$73.3K	0.67%	40
2021 Q4	$1.23M	Sell	21,994 -642	-3%	-$34.8K	0.66%	37
2021 Q3	$1.14M	Buy	+22,636	New	+$1.09M	0.66%	32